国际货币基金组织晚宴筹集了超过 675,000 美元用于抗击骨髓瘤

国际骨髓瘤基金会 (IMF) 在其第 15 届年度盛会上筹集了超过 675,000 美元，专门用于对抗骨髓瘤的研究和教育活动。该活动由名人和行业领袖参加，表彰了为骨髓瘤研究和患者支持做出贡献的组织。这些资金将专门支持彼得·博伊尔研究基金、黑天鹅研究计划以及解决骨髓瘤患者健康差异的项目。

International Myeloma Foundation Gala Raises Over $675,000 for Myeloma Research and Education

国际骨髓瘤基金会晚会为骨髓瘤研究和教育筹集了超过 675,000 美元

The International Myeloma Foundation (IMF) held its 15th annual gala in New York City in April, raising over $675,000 for groundbreaking myeloma research and educational initiatives. The event, recognized as a testament to the collective efforts and unwavering dedication of the myeloma community, was a resounding success.

国际骨髓瘤基金会 (IMF) 于 4 月在纽约市举办了第 15 届年度盛会，为突破性的骨髓瘤研究和教育计划筹集了超过 675,000 美元。该活动取得了巨大成功，被认为是骨髓瘤界集体努力和坚定奉献的证明。

"This gala is a celebration of our shared purpose and determination to conquer myeloma," remarked Yelak Biru, President and CEO of the IMF. "We unite patients, caregivers, researchers, doctors, supporters, and industry partners, guided by our unwavering commitment to finding a cure."

国际货币基金组织总裁兼首席执行官耶拉克·比鲁 (Yelak Biru) 表示：“这次盛会是对我们战胜骨髓瘤的共同目标和决心的庆祝。” “我们将患者、护理人员、研究人员、医生、支持者和行业合作伙伴团结起来，坚定不移地致力于寻找治疗方法。”

Highlighting the significance of research funding, Biru emphasized that "science and research require financial support, without which finding a cure for myeloma remains an elusive goal." The gala's success brings the IMF closer to its aspirations of advancing myeloma research and accelerating the path towards a definitive cure.

Biru 在强调研究经费的重要性时强调，“科学研究需要财政支持，如果没有财政支持，找到治疗骨髓瘤的方法仍然是一个难以实现的目标。”此次盛会的成功使国际货币基金组织更接近其推进骨髓瘤研究和加速最终治愈之路的愿望。

The event was graced by renowned actor and comedian Ray Romano, along with esteemed guest appearances by Tony Danza, Robert Klein, Patricia Heaton, and Alex Meneses. The evening served as a platform to honor the Peter Boyle Research Fund, established in memory of the actor who succumbed to myeloma, and the contributions it makes to advancing myeloma research.

著名演员兼喜剧演员雷·罗马诺 (Ray Romano) 以及托尼·丹扎 (Tony Danza)、罗伯特·克莱因 (Robert Klein)、帕特里夏·希顿 (Patricia Heaton) 和亚历克斯·梅内塞斯 (Alex Meneses) 等受人尊敬的嘉宾出席了此次活动。当晚是一个向彼得·博伊尔研究基金致敬的平台，该基金是为了纪念这位死于骨髓瘤的演员及其对推进骨髓瘤研究所做的贡献而设立的。

"We have made significant strides in myeloma through collaborative efforts between researchers, pharmaceutical companies, patients, and non-profit foundations," stated S. Vincent Rajkumar, MD, Chairman of the Board for the IMF. "The IMF's 15th Annual Gala celebrates these advancements and reinforces our unwavering commitment to ongoing research and patient support."

国际货币基金组织董事会主席、医学博士 S. Vincent Rajkumar 表示：“通过研究人员、制药公司、患者和非营利基金会之间的合作，我们在骨髓瘤治疗方面取得了重大进展。” “国际货币基金组织第 15 届年度晚会庆祝了这些进步，并强化了我们对持续研究和患者支持的坚定承诺。”

Several organizations were acknowledged for their invaluable contributions to myeloma research. The IMF Diversity, Equity, and Inclusion Award, recognizing efforts to address health disparities, was bestowed upon Johnson & Johnson. Tyrone Brewer, President of U.S. Hematology at Johnson & Johnson, expressed the company's dedication to ensuring equitable access to care and health outcomes regardless of individual circumstances.

一些组织因其对骨髓瘤研究的宝贵贡献而受到认可。国际货币基金组织多样性、公平和包容奖授予强生公司，以表彰其为解决健康差距所做的努力。强生公司美国血液学总裁 Tyrone Brewer 表示，该公司致力于确保无论个人情况如何，都能公平地获得护理和健康结果。

The Partner of the Year Award honored LatentView Analytics for its partnership with the IMF in streamlining the process from diagnosis to treatment, facilitating the timely initiation of therapy and improving patient outcomes. Rajan Sethuraman, CEO of LatentView, expressed gratitude for the recognition and highlighted the collaboration's positive impact on patient lives.

年度合作伙伴奖表彰 LatentView Analytics 与国际货币基金组织的合作，简化了从诊断到治疗的流程，促进及时开始治疗并改善患者的治疗效果。 LatentView 首席执行官 Rajan Sethuraman 对这一认可表示感谢，并强调了此次合作对患者生活的积极影响。

The IMF Innovation Award recognized the contributions of Bristol Myers Squibb and 2seventy bio in developing Abecma (idecabtagene vicleucel), a CAR T-cell therapy that has expanded approval for patients with hard-to-treat myeloma. The EU and other regulatory authorities have followed suit, demonstrating the potential of CAR T-cell therapies in addressing this challenging disease.

国际货币基金组织创新奖表彰了百时美施贵宝和 2seventy bio 在开发 Abecma (idecabtagene vicleucel) 方面做出的贡献，这是一种 CAR T 细胞疗法，扩大了对难治性骨髓瘤患者的批准。欧盟和其他监管机构也纷纷效仿，展示了 CAR T 细胞疗法在解决这一具有挑战性的疾病方面的潜力。

Carvykti (ciltacabtagene autoleucel), a BCMA-targeting CAR T-cell therapy developed by Janssen and Legend Biotech, has also recently received expanded approval in the U.S. and EU as a second-line treatment for relapsed or refractory multiple myeloma. This regulatory decision broadens the treatment options available to patients with progressive disease.

Carvykti (ciltacabtagene autoleucel) 是杨森和传奇生物科技开发的一种 BCMA 靶向 CAR T 细胞疗法，最近也在美国和欧盟获得了扩大批准，作为复发或难治性多发性骨髓瘤的二线治疗。这一监管决定拓宽了疾病进展患者的治疗选择。

The IMF's 15th Annual Gala stands as a testament to the tireless efforts and unwavering support of individuals and organizations committed to conquering myeloma. The funds raised will fuel groundbreaking research, foster educational initiatives, and empower patients with the knowledge and resources necessary to navigate their myeloma journey. As the search for a cure continues, the IMF remains steadfast in its mission to improve the lives of those affected by myeloma.

国际货币基金组织第 15 届年度晚会证明了致力于战胜骨髓瘤的个人和组织的不懈努力和坚定支持。筹集的资金将推动突破性的研究，促进教育举措，并为患者提供导航骨髓瘤之旅所需的知识和资源。随着寻找治疗方法的继续，国际货币基金组织仍然坚定不移地履行其改善骨髓瘤患者生活的使命。